EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Ginkgo biloba Extract for Intermittent Claudication in Patients with Peripheral Arterial Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Haengjin Ohe iD, Jinhee Hwang, Suk Ran Kim iD, Seonwoo Kim, Sun Cheol Park iD

Journal of Clinical Medicine · 04.11.2026 · 15 (21) · 8606

DOI: 10.3390/jcm15218606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.11.2026. Verfasst von Haengjin Ohe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Transplant Surgery, Department of Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republi…. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SK Chemicals (South Korea), SK Chemicals Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Intermittent claudication (IC) secondary to peripheral artery disease (PAD) causes exertional leg pain and discomfort, which limits functional walking capacity. The clinical efficacy of Ginkgo biloba extract (GBE) as a therapeutic agent for IC is debatable. This systematic review and meta-analysis evaluated the efficacy and safety of GBE compared with a placebo in patients with IC due to PAD.

Methods

Databases including PubMed, Embase, the Cochrane Library, and CINAHL were searched until 24 April 2026. Eligible studies included randomized, double-blind, controlled trials (RCTs) comparing placebo. Primary outcome was absolute claudication distance (ACD) at the end of the study. Secondary outcomes were initial claudication distance (ICD), ankle-brachial index (ABI), ankle pressure, and adverse events. Walking outcomes across various treadmill protocols were standardized to estimate caloric expenditure (kcal). A random-effects model was used to pool the effect estimates across trials. Risk of bias was assessed using the Cochrane risk-of-bias tool (RoB 2).

Results

A total of 14 RCTs comprising 893 participants represent the total number randomized were included. GBE was associated with a statistically significant but modest improvement in ACD compared with placebo (mean difference [MD], 3.50 kcal; 95% CI, 0.02 to 6.98; p = 0.049). This benefit was significant in trials with a 24-week duration (MD, 4.67 kcal; 95% CI, 2.26 to 7.08; p < 0.001) but not in 12–16 weeks trials (MD, 1.35 kcal; 95% CI, −2.39 to 5.09; p = 0.48). No significant changes were observed for ICD or resting ABI/ankle pressure. GBE was well tolerated, with an overall adverse event incidence comparable to placebo.

Conclusions

In patients with IC due to PAD, GBE therapy improves absolute walking performance, with a significant effect observed in trials evaluating 24 weeks of treatment. Given its favorable safety and tolerability profile, GBE can represent a clinically relevant and well-tolerated therapeutic option to support functional walking capacity, particularly for patients unable to tolerate or use conventional pharmacological agents.

Schlagwörter

Stichwörter der Autor:innen

Ginkgo biloba extractabsolute claudication distanceintermittent claudicationmeta-analysisperipheral artery diseasesystematic review

Autor:innen und Institutionen

  • Division of Vascular and Transplant Surgery, Department of Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Academic Research Service Department, LSK Global Pharma Services Co., Ltd., Seoul 04535, Republic of Korea.
  • Clinical Strategy Department, LSK Global Pharma Services Co., Ltd., Seoul 04535, Republic of Korea.

ORCID-Profile: Haengjin Ohe, Suk Ran Kim, Sun Cheol Park

Förderung

  • SK Chemicals (South Korea)
  • SK Chemicals Co., Ltd.

Zitieren

APA

Ohe, H., Hwang, J., Kim, S. R., Kim, S., & Park, S. C. (2026). Ginkgo biloba Extract for Intermittent Claudication in Patients with Peripheral Arterial Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine, 15(21), 8606. https://doi.org/10.3390/jcm15218606

Vancouver

Ohe H, Hwang J, Kim SR, Kim S, Park SC. Ginkgo biloba Extract for Intermittent Claudication in Patients with Peripheral Arterial Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine. 2026;15(21):8606. doi:10.3390/jcm15218606

BibTeX
@article{Ohe2026,
  author = {Ohe, Haengjin and Hwang, Jinhee and Kim, Suk Ran and Kim, Seonwoo and Park, Sun Cheol},
  title = {Ginkgo biloba Extract for Intermittent Claudication in Patients with Peripheral Arterial Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8606},
  doi = {10.3390/jcm15218606}
}
Kostenlos starten →